Mankind Pharma enters US market, invests Rs.300 crore

New Delhi, Jan 21 (IANS) Indian pharmaceutical company Mankind Pharma on Thursday announced its entry into the US market with an investment of Rs.300 crore.

“We wish to become a multi-national pharma company by tapping the foreign markets. We aim to place ourselves amongst the top three pharmaceutical companies of India. The US market will come up with new innovative products which will further distinguish us from others,” Mankind Pharma chairman and founder R.C. Juneja said in a statement.

Aiming for a revenue of Rs.1,000 crore from the international market by 2030, Mankind Pharma is focusing on implementing the same affordable healthcare strategy in the US as in India, the statement said.

Founded in 1995, Mankind Pharma currently employs more than 12,000 people, and has a turnover of around Rs.5,000 crore.

Leave a Reply

Please enter your comment!

The opinions, views, and thoughts expressed by the readers and those providing comments are theirs alone and do not reflect the opinions of www.mangalorean.com or any employee thereof. www.mangalorean.com is not responsible for the accuracy of any of the information supplied by the readers. Responsibility for the content of comments belongs to the commenter alone.  

We request the readers to refrain from posting defamatory, inflammatory comments and not indulge in personal attacks. However, it is obligatory on the part of www.mangalorean.com to provide the IP address and other details of senders of such comments to the concerned authorities upon their request.

Hence we request all our readers to help us to delete comments that do not follow these guidelines by informing us at  info@mangalorean.com. Lets work together to keep the comments clean and worthful, thereby make a difference in the community.

Please enter your name here